Haleon PLC
HLN
ISIN null / Valor 120042697
Haleon PLC
UMushroom community rating:
About company
Haleon PLC is a global consumer healthcare company that was spun out of GlaxoSmithKline and listed on the London Stock Exchange in 2022; it develops, manufactures and markets over‑the‑counter medicines, oral care products, vitamins, minerals and supplements and other self‑care treatments. The company markets a portfolio of established consumer brands, including Sensodyne and Centrum, across categories such as oral health, pain relief, digestive and respiratory care, selling through pharmacies, supermarkets and e‑commerce channels worldwide. As a standalone public company, Haleon combines product development, manufacturing, distribution and commercial functions to support brand-led growth in both developed and emerging markets.
Summarized from source with an LLMView SourceSector: Business ServicesKey figures
Performance
Volatility
49580 M
Market cap (USD)
5,482,462
Daily traded volume (Shares)
9.56 / 9.44
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
